Dendritic Cells Are the Major Antigen Presenting Cells in Inflammatory Lesions of Murine Mycoplasma Respiratory Disease

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Sun, Xiangle ^a   Jones, Harlan P ^a   Dobbs, Nicole ^a   Bodhankar, Sheetal ^a   Simecka, Jerry W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE ASSOCIATION; EPERYTHROZOONOSIS; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LUNG INFILTRATE; MACROPHAGE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; RESPIRATORY TRACT DISEASE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD11C; ANTIGENS, DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; LUNG; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MYCOPLASMA; MYCOPLASMA INFECTIONS; PNEUMONIA, MYCOPLASMA; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 84873490864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055984     Document Type: Article

References (53)

1. Cassell GH, (1982) Derrick Edward Award Lecture The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. Rev Infect Dis 4 Suppl: S18-34.
2. Foy HM, (1993) Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 17 Suppl 1: S37-46.
3. Krause DC, Taylor-Robinson D (1993) Mycoplasmas which infect humans. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: Molecular biology and pathogenesis. Washington, D.C.: American Society of Microbiology. pp. 417-444.
4. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH, (2001) A link between chronic asthma and chronic infection. J Allergy Clin Immunol 107: 595-601.
5. Dajani AS, Clyde WA Jr, Denny FW, (1965) Experimental infection with Mycoplasma pneumoniae (Eaton's agent). Journal of Experimental Medicine 121: 1071.
6. Cassell GH, Lindsey JR, Overcash RG, Baker HJ, (1973) Murine mycoplasma respiratory disease. Ann N Y Acad Sci 225: 395-412.
7. Cartner SC, Simecka JW, Lindsey JR, Cassell GH, Davis JK, (1995) Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect Immun 63: 4138-4142.
8. Yancey AL, Watson HL, Cartner SC, Simecka JW, (2001) Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice. Infect Immun 69: 2865-2871.
9. Evengard B, Sandstedt K, Bolske G, Feinstein R, Riesenfelt-Orn I, et al. (1994) Intranasal inoculation of Mycoplasma pulmonis in mice with severe combined immunodeficiency (SCID) causes a wasting disease with grave arthritis. Clinical & Experimental Immunology 98: 388-394.
10. Cartner SC, Lindsey JR, Gibbs-Erwin J, Cassell GH, Simecka JW, (1998) Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect Immun 66: 3485-3491.
11. Sandstedt K, Berglof A, Feinstein R, Bolske G, Evengard B, et al. (1997) Differential susceptibility to Mycoplasma pulmonis intranasal infection in X-linked immunodeficient (xid), severe combined immunodeficient (scid), and immunocompetent mice. Clin Exp Immunol 108: 490-496.
12. Keystone EC, Taylor-Robinson D, Osborn MF, Ling L, Pope C, et al. (1980) Effect of T-cell deficiency on the chronicity of arthritis induced in mice by Mycoplasma pulmonis. Infection and Immunity 27: 192-196.
13. Taylor G, Taylor-Robinson D, Fernald GW, (1974) Reduction of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera. Journal of Medical Microbiology 7: 343.
14. Jones H, Tabor L, Sun X, Woolard M, Simecka J, (2002) Depletion of CD8+ T cells exacerbates CD4+ Th cell associated inflammatory lesions during murine mycoplasma respiratory disease. Journal of Immunology 168: 3493-3501.
15. Bodhankar S, Sun X, Woolard MD, Simecka JW, (2010) Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease. The Journal of infectious diseases 202: 39-51.
16. Woolard MD, Hodge LM, Jones HP, Schoeb TR, Simecka JW, (2004) The upper and lower respiratory tracts differ in their requirement of IFN-gamma and IL-4 in controlling respiratory mycoplasma infection and disease. J Immunol 172: 6875-6883.
17. Roncarolo M-G, Levings MK, Traversari C, (2001) Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 193: F5-F9.
18. Dhodapkar M, Steinman RM, Krasovsky J, Munz C, Bhardwaj N, (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193: 233-238.
19. Bilyk N, Holt PG, (1995) Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 86: 231-237.
20. McWilliam AS, Nelson DJ, Holt PG, (1995) The biology of airway dendritic cells. Immunology & Cell Biology 73: 405-413.
21. Stumbles PA, Thomas JA, Pimm CL, Lee PT, Venaille TJ, et al. (1998) Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 188: 2019-2031.
22. Nicod LP, Lipscomb MF, Weissler JC, Lyons CR, Albertson J, et al. (1987) Mononuclear cells in human lung parenchyma. Characterization of a potent accessory cell not obtained by bronchoalveolar lavage. Am Rev Respir Dis 136: 818-823.
23. Pollard AM, Lipscomb MF, (1990) Characterization of murine lung dendritic cells: similarities to Langerhans cells and thymic dendritic cells. J Exp Med 172: 159-167.
24. Masten BJ, Yates JL, Pollard Koga AM, Lipscomb MF, (1997) Characterization of accessory molecules in murine lung dendritic cell function: roles for CD80, CD86, CD54, and CD40L. Am J Respir Cell Mol Biol 16: 335-342.
25. Masten BJ, Lipscomb MF, (1999) Comparison of lung dendritic cells and B cells in stimulating naive antigen-specific T cells. J Immunol 162: 1310-1317.
26. Simecka JW, Thorp RB, Cassell GH, (1992) Dendritic cells are present in the alveolar region of lungs from specific pathogen-free rats. Reg Immunol 4: 18-24.
27. Banchereau J, Steinman RM, (1998) Dendritic cells and the control of immunity. Nature 392: 245-252.
28. Cochand L, Isler P, Songeon F, Nicod LP, (1999) Human lung dendritic cells have an immature phenotype with efficient mannose receptors. Am J Respir Cell Mol Biol 21: 547-554.
29. Lambrecht BN, Carro-Muino I, Vermaelen K, Pauwels RA, (1999) Allergen-induced changes in bone-marrow progenitor and airway dendritic cells in sensitized rats. Am J Respir Cell Mol Biol 20: 1165-1174.
30. Moller GM, Overbeek SE, Van Helden-Meeuwsen CG, Van Haarst JM, Prens EP, et al. (1996) Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 26: 517-524.
31. Bertorelli G, Bocchino V, Zhou X, Zanini A, Bernini MV, et al. (2000) Dendritic cell number is related to IL-4 expression in the airways of atopic asthmatic subjects. Allergy 55: 449-454.
32. Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA, (1998) Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160: 4090-4097.
33. Lambrecht BN, De Veerman M, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, et al. (2000) Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest 106: 551-559.
34. Sung S, Rose CE, Fu SM, (2001) Intratracheal priming with ovalbumin- and ovalbumin 323-339 peptide-pulsed dendritic cells induces airway hyperresponsiveness, lung eosinophilia, goblet cell hyperplasia, and inflammation. J Immunol 166: 1261-1271.
35. Hammad H, Duez C, Fahy O, Tsicopoulos A, Andre C, et al. (2000) Human dendritic cells in the severe combined immunodeficiency mouse model: their potentiating role in the allergic reaction. Lab Invest 80: 605-614.
36. Sun X, Jones HP, Hodge LM, Simecka JW, (2006) Cytokine and chemokine transcription profile during Mycoplasma pulmonis infection in susceptible and resistant strains of mice: macrophage inflammatory protein 1beta (CCL4) and monocyte chemoattractant protein 2 (CCL8) and accumulation of CCR5+ Th cells. Infect Immun 74: 5943-5954.
37. Vermaelen K, Pauwels R, (2004) Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights. Cytometry Part A: the journal of the International Society for Analytical Cytology 61: 170-177.
38. Osterholzer JJ, Milam JE, Chen GH, Toews GB, Huffnagle GB, et al. (2009) Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans. Infect Immun 77: 3749-3758.
39. Lambrecht BN, Hammad H, (2012) Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu Rev Immunol 30: 243-270.
40. Bjorck P, (2001) Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 98: 3520-3526.
41. Nakano H, Yanagita M, Gunn MD, (2001) CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 194: 1171-1178.
42. Villadangos JA, Schnorrer P, Wilson NS, (2005) Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. Immunological reviews 207: 191-205.
43. Wilson NS, Villadangos JA, (2005) Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Advances in immunology 86: 241-305.
44. Delamarre L, Holcombe H, Mellman I, (2003) Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 198: 111-122.
45. Faulkner L, Buchan G, Baird M, (2000) Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation. Immunology 99: 523-531.
46. Simecka JW (2005) Immune responses following mycoplasma infection. In: Blanchard A, Browning G, editors. Mycoplasmas Molecular biology, pathogenicity and strategies for control. Norfolk, U.K.: Horizon Bioscience. pp. 485-534.
47. Simecka JW (2003) Contrasting roles of immunity in mycoplasma respiratory disease. Recent Research Developments in Infection and Immunity: Transworld Research Network. pp. 203-219.
48. Jones HP, Simecka JW, (2003) T lymphocyte responses are critical determinants in the pathogenesis and resistance to Mycoplasma respiratory disease. Front Biosci 8: D930-945.
49. Cartner SC, Simecka JW, Briles DE, Cassell GH, Lindsey JR, (1996) Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect Immun 64: 5326-5331.
50. Davidson MK, Lindsey JR, Parker RF, Tully JG, Cassell GH, (1988) Differences in virulence for mice among strains of Mycoplasma pulmonis. Infection and Immunity 56: 2156-2162.
51. Roederer M, (2001) Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45: 194-205.
52. Horowitz SA, Garrett B, Davis JK, Cassell GH, (1987) Isolation of Mycoplasma pulmonis membranes and identification of surface antigens. Infect Immun 55: 1314-1320.
53. Simecka JW, Cassell GH, (1987) Serum antibody and cellular responses in LEW and F344 rats after immunization with Mycoplasma pulmonis antigens. Infect Immun 55: 731-735.